Let’s be real, does infrequent smoking really accelerate MPB and/or cause health issues? 9/7/2026
Smoking infrequently is unlikely to significantly impact hair loss or health, especially when using treatments like finasteride and minoxidil. Genetics play a larger role in hair loss, and low smoking frequency is not considered a major risk.
View this post in the Community →
Similar Community Posts Join
6 / 6 resultscommunity The Association between Sugar-Sweetened Beverages and Male Pattern Hair Loss in Young Men
Excessive sugar consumption may contribute to male pattern hair loss by increasing androgen sensitivity and insulin resistance, but genetics play a significant role. Treatments like minoxidil and finasteride are suggested for managing hair loss, while reducing sugar intake and maintaining a healthy lifestyle may help mitigate its progression.
community Is DHT actually the cause of male pattern hair loss or just a correlating factor? Why I think the research is more complicated than we're told and why I've been looking into GHK-Cu
DHT is not the only cause of male pattern hair loss; genetic sensitivity, inflammation, and fibrosis also contribute. GHK-Cu, a copper peptide, is being explored as an alternative treatment to finasteride and minoxidil, showing potential in improving follicle health.
community Stressing out leads to hair loss. Staying positive and believing you will grow hair actually slows down MPB and can sometimes cause some hair growth.
Staying positive and managing stress may slow hair loss, but treatments like finasteride, minoxidil, and dutasteride are essential for managing male pattern baldness. Stress can accelerate hair loss, but genetics play a significant role, and early treatment is crucial.
community 3 months into treatment... I'm I hyper responsive?
A 26-year-old male started minoxidil treatment for male-pattern baldness and saw significant regrowth in three months. He is considering finasteride but is hesitant due to potential side effects.
community PSA: If you're prone to MPB dont take creatine
Creatine might speed up hair loss in those prone to male pattern baldness, possibly due to increased DHT levels. Some users experience no issues when using creatine with treatments like finasteride, minoxidil, or dutasteride.
community If we can clone a sheep why we can't cure baldness till now
Hair loss treatments like Minoxidil, finasteride, and stem cell therapies exist, but a complete cure is hindered by genetic complexity and market dynamics. Cloning hair follicles is considered a potential solution, but it's currently not feasible.
Related Research
6 / 6 resultsresearch The genetically programmed hair growth cycle and alopecia: what is there to know?
This review discusses recent advances in hair follicle research, highlighting therapeutic and cosmetic applications, but reports no new study results.
research The endocrinology of baldness
Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.
research Pharmacologic interventions in aging hair
This review discusses factors affecting hair aging and the current pharmacological treatments for androgenetic alopecia, mentioning topical minoxidil and oral finasteride, but does not present new clinical findings.
research Hair, Hormones, and High-Risk Prostate Cancer
This study observed that men with frontal and moderate vertex baldness between ages 40 and 50 had a higher risk of aggressive prostate cancer, suggesting a potential link between baldness pattern and cancer risk.
research Controversy: is there a role for adjuvants in the management of male pattern hair loss?
This article reviews current hair loss treatments, proposing a hypothesis that a combination of drugs, supplements, and therapies may effectively manage hair loss, but presents no new clinical results.
research Large-Scale Plasma Proteomics and Genetic Integration Uncover Novel Biological Pathways in Male Pattern Baldness
In this study, researchers identified 47 proteins associated with male pattern baldness severity and prioritized five candidate genes, including druggable CD38, suggesting new non-hormonal targets for therapeutic development.